Strict security & compliance needs
Pharma must meet demanding standards (HIPAA, GDPR, FDA 21 CFR Part 11) for data protection, access control, and auditability.
Identity solutions for global pharma.
Deliver seamless, secure experiences across trials, patient services, and HCP engagement — with full regulatory alignment.
In pharma, identity is critical to everything from clinical trial access and patient portals to HCP engagement and global compliance. Whether you're enabling self-service for patients or streamlining provider access, secure and seamless identity is a foundation for trust — and a requirement for compliance.
The shift
Identity is essential to pharma innovation and engagement
Digital transformation in pharma is accelerating — but identity remains a bottleneck for usability, compliance, and scale. Getting it right means removing friction, supporting global access, and meeting strict regulatory standards.
- Ambition outpaces infrastructure. Pharma leaders prioritize digital engagement, but many lack confidence in the identity systems meant to support it.
- HCP drop-off risk. Healthcare professionals abandon portals when login and authentication create friction at the worst moment.
- Global scale, local complexity. Operating across regions and brands multiplies the cost of fragmented, inflexible identity infrastructure.
81%
of pharma leaders say digital engagement is critical, but only 30% are confident in their identity systems (Deloitte)
52%
of healthcare professionals abandon portals due to login or authentication issues (PharmaVoice)
70%
of pharma companies operate in 10+ countries, complicating identity management across regions and brands (IQVIA)
Challenges
Common CIAM challenges in pharma
From clinical trials to commercial engagement, identity challenges increase cost and reduce effectiveness.
Global & multilingual access
Managing users across regions, languages, and regulatory zones is complex without centralized, flexible identity infrastructure.
Fragmented portals for patients & HCPs
Clinical trials, support programs, and provider tools often live in silos with disconnected logins and poor UX.
High abandonment & low engagement
Long or error-prone sign-up flows and forgotten credentials hurt adoption of critical portals and apps.
Rigid, costly legacy systems
Outdated CIAM platforms limit scalability and innovation — especially when supporting multiple brands or therapeutic areas.
Lack of identity-driven consent control
Supporting granular, auditable consent preferences across brands, uses, and regions is essential but often unsupported.
CIAM for pharma
How we help pharmaceutical companies
Next Reason supports pharmaceutical leaders with secure, scalable, and compliant identity services that improve access and engagement — while reducing risk and complexity.
CIAM modernization & migration
Replace legacy identity systems with scalable, policy-aligned platforms built for multi-brand, multi-market pharma operations.
Application & experience onboarding
Connect identity across patient portals, HCP tools, clinical trial systems, and commercial apps with proven onboarding frameworks.
Identity operations & support
Ensure high availability and incident response for mission-critical identity services with 24×7 operational coverage.
CIAM innovation
Implement advanced flows — ID verification, progressive profiling, role-based access, multilingual UX, and consent management aligned with pharma regulation.
Outcomes
Results that matter
Build trust, deliver faster, and meet the highest standards.
Boost patient & HCP adoption
Reduce friction and abandonment across all portals with user-friendly, branded, and localized identity experiences.
Simplify global compliance
Support HIPAA, GDPR, and other frameworks with configurable consent, audit trails, and access controls.
Unify identity across brands
Manage identity across multiple therapeutic areas and regions — without duplicating infrastructure or losing control.
Case studies
Programs we have owned to the cutover.
Scope, platform, and the outcome that mattered—run end-to-end by senior CIAM architects.
Global Pharma Migration
Case Study: A global pharma leader de-risks a multi-year CIAM migration
How a Fortune Global 500 pharmaceutical company validated its identity and consent architecture before execution, with Next Reason, Akamai's Customer Migration Center of Excellence…
Global Pharmaceuticals
Case Study: CIAM Implementation Across Borders
When a Global Pharmaceuticals sought to modernize its CIAM platform, they partnered with Next Reason to assess its complex IT landscape, implement a robust CIAM platform, migrate m…